InvestorsHub Logo
Post# of 251943
Next 10
Followers 829
Posts 119691
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 196849

Thursday, 03/03/2016 9:49:44 AM

Thursday, March 03, 2016 9:49:44 AM

Post# of 251943
OCRX—STOP-HE trial now 2/3 enrolled (150 of 230 patients) and is on track for completion of enrollment by end of 2016 (according to today’s PR: #msg-120933504).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.